RYTRX | VSIAX | RYTRX / VSIAX | |
Total Expense Ratio | 1.26 | 0.07 | 1,800% |
Annual Report Gross Expense Ratio | 1.26 | 0.07 | 1,800% |
Fund Existence | 31 years | 14 years | - |
Gain YTD | -10.227 | -10.925 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 857M | 53.6B | 2% |
Annual Yield % from dividends | 3.00 | 2.27 | 133% |
Returns for 1 year | -4.31 | -3.10 | 139% |
Returns for 3 years | -11.28 | 4.76 | -237% |
Returns for 5 years | -5.38 | 92.61 | -6% |
Returns for 10 years | -46.70 | 68.74 | -68% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBRN | 22.06 | 0.38 | +1.76% |
iShares Neuroscience and Healthcare ETF | |||
XJUN | 38.04 | 0.41 | +1.09% |
FT Vest US Eq Enh&Mod Bffr ETF June | |||
SPBO | 28.71 | 0.24 | +0.84% |
SPDR® Portfolio Corporate Bond ETF | |||
PTMC | 34.67 | 0.04 | +0.10% |
Pacer Trendpilot™ US Mid Cap ETF | |||
MKOR | 22.02 | N/A | N/A |
Matthews Korea Active ETF |